New Infrastructure Contracts and Biotech Maneuvers: The Latest Sector ShakeupGlobal Report·Aug 9 at 04:12 AMGNPX-2.08%LIMN+3.07%
The Biotech Divide of 2026: Commercial Titans vs. AI HopefulsGlobal Report·Aug 8 at 04:21 AMRAIN-2.62%GENB+0.38%
Market Sentiment Bifurcates: What 10 Niche Equities Signal About the Broader EconomyGlobal Report·Aug 7 at 04:18 AMGNPX-2.08%FIVN-2.86%
The Market's Unbundled Periphery: From AI Energy to Niche HealthcareGlobal Report·Aug 6 at 04:15 AMVSEE+0.34%PBK+1.49%
Genprex must keep Nasdaq bid price at or above $1 through Dec. 7 to retain listingPUBT·Aug 5 at 05:14 PMGNPX-2.08%
Strategic Pivots and Financing Deals: How 10 US Stocks Are Navigating 2026Global Report·Aug 5 at 04:13 AMYYGH+3.76%NCLH-2.37%
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga_article·Aug 3 at 12:05 PMUPC+3.42%GNPX-2.08%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Aug 3 at 07:06 AMGLMD+6.82%AMIX-6.44%
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies | GNPX Stock NewsStockTitan·Aug 2 at 10:00 PMGNPX-2.08%RHHBY+1.56%
Genprex wins Nasdaq exception to stay listed, must keep shares above $1 through Dec. 7PUBT·Jul 30 at 04:03 PMGNPX-2.08%
Pre-market hot trades in US stocks: Genprex up 10.00% in pre-market; Sumitomo Mitsui Financial down 3.81% in pre-marketPrice Alert·Jul 17 at 05:17 AMGNPX-2.08%SMFG-0.51%
Genprex’s Reqorsa combo secures Canadian patent for lung cancerPharmaceutical Technology·Jun 23 at 04:51 AMGNPX-2.08%
